Original article
Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors
M. Serinoa,
, C. Freitasc, M. Martinsa, P. Ferreiraa, C. Cardosoa, F. Veigab, V. Santosa, D. Araújoa, H. Novais-Bastosc, A. Magalhãesa, H. Queirogac, G. Fernandesc, V. Hespanholc
Corresponding author
mariana.serino@gmail.com
Corresponding author at: Centro Hospitalar Universitário de São João: Centro Hospitalar Universitario de Sao Joao, Portugal.
Corresponding author at: Centro Hospitalar Universitário de São João: Centro Hospitalar Universitario de Sao Joao, Portugal.
Read
5643
Timeswas read the article
1645
Total PDF
3998
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 67 | 30 | 97 |
| 2025 5 | 189 | 72 | 261 |
| 2025 4 | 95 | 55 | 150 |
| 2025 3 | 125 | 51 | 176 |
| 2025 2 | 93 | 41 | 134 |
| 2025 1 | 80 | 53 | 133 |
| 2024 12 | 72 | 44 | 116 |
| 2024 11 | 101 | 64 | 165 |
| 2024 10 | 99 | 41 | 140 |
| 2024 9 | 109 | 52 | 161 |
| 2024 8 | 451 | 77 | 528 |
| 2024 7 | 683 | 100 | 783 |
| 2024 6 | 72 | 31 | 103 |
| 2024 5 | 89 | 59 | 148 |
| 2024 4 | 57 | 31 | 88 |
| 2024 3 | 68 | 22 | 90 |
| 2024 2 | 52 | 29 | 81 |
| 2024 1 | 57 | 34 | 91 |
| 2023 12 | 30 | 19 | 49 |
| 2023 11 | 81 | 81 | 162 |
| 2023 10 | 66 | 42 | 108 |
| 2023 9 | 69 | 32 | 101 |
| 2023 8 | 34 | 21 | 55 |
| 2023 7 | 58 | 32 | 90 |
| 2023 6 | 59 | 17 | 76 |
| 2023 5 | 95 | 47 | 142 |
| 2023 4 | 79 | 16 | 95 |
| 2023 3 | 115 | 18 | 133 |
| 2023 2 | 74 | 27 | 101 |
| 2023 1 | 47 | 23 | 70 |
| 2022 12 | 64 | 29 | 93 |
| 2022 11 | 93 | 45 | 138 |
| 2022 10 | 70 | 32 | 102 |
| 2022 9 | 57 | 36 | 93 |
| 2022 8 | 46 | 41 | 87 |
| 2022 7 | 85 | 61 | 146 |
| 2022 6 | 53 | 38 | 91 |
| 2022 5 | 58 | 41 | 99 |
| 2022 4 | 106 | 61 | 167 |
Show all
